Jill Massey

Statistics

Publications

Citations

104

H-Index

Active since

1984

Affiliations

Melinta Therapeutics (United States)(Current)

Jill Massey is an author at Melinta Therapeutics (United States) specializing in antibacterial therapy, pharmacotherapy, and combination antimicrobial therapy.

Publications per year

1984–2019

Publications

The CHROME Study, a Real-world Experience of Single- and Multiple-Dose Oritavancin for Treatment of Gram-Positive Infections

Mark Redell, Miguel Sierra‐Hoffman, Maha Assi et al. · Open Forum Infectious Diseases · 2019 · 47 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16

Efficacy and Safety of Meropenem–Vaborbactam Versus Best Available Therapy for the Treatment of Carbapenem-Resistant Enterobacteriaceae Infections in Patients Without Prior Antimicrobial Failure: A Post Hoc Analysis

Matteo Bassetti, Daniele Roberto Giacobbe, Niki Patel et al. · Advances in Therapy · 2019 · 45 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Utilization of sodium dodecyl sulphate by denitrifying bacteria under anaerobic conditions

K. S. Dodgson, Graham F. White, Jill Massey et al. · FEMS Microbiology Letters · 1984 · 12 citations · Full text

Life Sciences, Biochemistry, Microbiology +17

1–3 of 3